|
1
|
Why renal biopsy is crucial in monoclonal gammopathy of renal significance (MGRS). Int Urol Nephrol 2019; 51:899-900. [DOI: 10.1007/s11255-019-02131-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2019] [Accepted: 03/12/2019] [Indexed: 10/27/2022]
|
|
2
|
Ciocchini M, Musso CG. Which should be the correct treatment for monoclonal gammopathy of renal significance with complement alternative pathway dysregulation (C3 glomerulopathy and atypical hemolytic uremic syndrome): clone-directed or anticomplement therapy? Int Urol Nephrol 2018; 50:1365-1366. [PMID: 29808447 DOI: 10.1007/s11255-018-1896-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2018] [Accepted: 05/15/2018] [Indexed: 10/14/2022]
Affiliation(s)
- Mariana Ciocchini
- Daomi Institute affiliated to Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.
| | - Carlos G Musso
- Nephrology Division, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| |
Collapse
|